State Pharmaceuticals Corporation of Sri Lanka

Last updated • 3 min readFrom Wikipedia, The Free Encyclopedia

State Pharmaceuticals Corporation of Sri Lanka
AbbreviationSPC
FormationMarch 1971;52 years ago (1971-03)
Legal status Corporation body
Headquarters Colombo, Sri Lanka
Sarath Liyanage
Website www.spc.lk/index.php

The State Pharmaceuticals Corporation (SPC) is a state-owned enterprise with its headquarters in Colombo, Sri Lanka. It is the largest supplier of drugs in the country, and is tasked with providing quality-assured health care items that are safe and effective, at an affordable price, while educating the public on the rational use of drugs. It employees about 600 staff.

Contents

History

The SPC was established in 1971 under the State Industrial Corporations Act Number 49 of 1957, as a result of the Report in March of that year of the Bibile - Wickramasinghe commission, appointed by the then Prime Minister Sirimavo Bandaranaike. Its founder chairman was Professor Seneka Bibile.

The SPC channelled all imports and production of pharmaceuticals, calling for worldwide bulk tenders which were limited to the approved drugs listed in the National Formulary. The public and private health sectors had to obtain all their requirements from the SPC. Hence the stranglehold of the Multinational corporations on the drug trade was successfully broken and they were made to compete with each other and with generic drug producers, enabling the country to obtain drugs much cheaper. Branded drugs were replaced by generic drugs in the prescription and sale of medicines.

In 1972 the SPC imported 52 drugs at a third of their previous prices. In 1973, the SPC itself bought the raw material necessary for 14 private processing laboratories established in the island. Some drug prices dropped by half or two-thirds. The SPC bought from an Indian company the raw material necessary for a widely used tranquilliser at a much lower price than that charged by a Swiss multinational.

The Prescriber, a quarterly publication edited by the National Formulary Committee, was published by the SPC and distributed to all medical personnel. The extravagant promotional practices of drugs manufacturers were stopped to remove the dangers and costs inherent in process.

With the election of the Multi-National-friendly United National Party Government of 1977, the SPC was called upon to compete with the private sector. There was continued government control of the types of drugs imported, but permission was given to the private sector to import multiple brands. The SPC was never dissolved and continued to supply affordable drugs, continuing to be responsible for centralised procurement for the government health sector.

Sales network

The SPC the sole supplier of pharmaceuticals, surgical consumable items, laboratory chemicals and equipment to all institutions administered by the Ministry of Health. At the same time it is the largest supplier to the private sector, with a 30% market share. The retail outlets of the SPC are called Rajya Osu Salas (state drug shops), of which there are 18. In addition, there are 36 Franchise Osu Salas 48 Distributors and 20 Authorized Retailers spread throughout the country.

The original Rajya Osu Sala in Colombo 7 operates 24 hours a day and 365 days a year.

Products

The SPC provides about 2000 drugs, covering a wide spectrum of pharmacological activity, at some of the lowest prices in the world.

Quality assurance

All pharmaceuticals supplied by the SPC are subject to quality testing by the Quality Assurance Laboratory at the Head Office.

Information services

It is essential that correct information on drugs and therapeutics be given to all medical personnel and also to the general public.

Related Research Articles

<i>British National Formulary</i> Pharmaceutical reference book for the UK

The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS). Information within the BNF includes indication(s), contraindications, side effects, doses, legal classification, names and prices of available proprietary and generic formulations, and any other notable points. Though it is a national formulary, it nevertheless also includes entries for some medicines which are not available under the NHS, and must be prescribed and/or purchased privately. A symbol clearly denotes such drugs in their entry.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

The Pharmaceutical Benefits Scheme (PBS) is a program of the Australian Government that subsidises prescription medication for Australian citizens and permanent residents, as well as international visitors covered by a reciprocal health care agreement. The PBS is separate to the Medicare Benefits Schedule, a list of health care services that can be claimed under Medicare, Australia's universal health care insurance scheme.

Pharmaceutical marketing is a branch of marketing science and practice focused on the communication, differential positioning and commercialization of pharmaceutical products, like specialist drugs, biotech drugs and over-the-counter drugs. By extension, this definition is sometimes also used for marketing practices applied to nutraceuticals and medical devices.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Senaka Bibile was a Sri Lankan pharmacologist. He was the founder of Sri Lanka's drug policy, which was used as a model for development of policies based on rational pharmaceutical use in other countries as well by the World Health Organization, the United Nations Conference on Trade and Development (UNCTAD) and the Non-Aligned Movement. Due to the far reaching effects of his proposals and policies, he has been called the 'greatest medical benefactor of humanity that Sri Lanka has hitherto produced'.

An essential medicines policy is one that aims at ensuring that people get good quality drugs at the lowest possible price, and that doctors prescribe the minimum of required drugs in order to treat the patient's illness. The pioneers in this field were Sri Lanka and Chile.

The Sri Lanka National Pharmaceuticals Policy was established in the 1970s following the submission of a report by Dr S.A. Wickremasinghe and Prof. Seneka Bibile. It aimed at ensuring that people get good quality drugs at the lowest possible price and that doctors would prescribe the minimum required drugs to treat the patient's illness. It was a pioneer in the field of rational National pharmaceuticals policy.

The National Medicinal Drugs Policy is an essential part of Sri Lanka's Health Policy, aimed at the rational use of pharmaceuticals.

Pharmacy and Therapeutics (P&T) is a committee at a hospital or a health insurance plan that decides which drugs will appear on that entity's drug formulary. The committee usually consists of healthcare providers involved in prescribing, dispensing, and administering medications, as well as administrators who evaluate medication use. They must weigh the costs and benefits of each drug and decide which ones provide the most efficacy per dollar. This is one aspect of pharmaceutical policy. P&T committees utilize an evidence-based approach to drive change within health systems/plans by changing existing policies and bringing up-to-date research to support medical decision-making.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

Many developing nations have developed national drug policies, a concept that has been actively promoted by the WHO. For example, the national drug policy for Indonesia drawn up in 1983 had the following objectives:

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs, biologics, vaccines and natural health products.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

<span class="mw-page-title-main">Healthcare in Sri Lanka</span>

Sri Lanka has a free and universal health care system. It scores higher than the regional average in healthcare having a high Life expectancy and a lower maternal and infant death rate than its neighbors. It is known for having one of the world's earliest known healthcare systems and has its own indigenous medicine system.

<i>Irish Medicines Formulary</i>

Irish Medicines Formulary (IMF) is a medicines reference for doctors, nurses, pharmacists and dentists, providing medicines information which is medico-legally relevant in Ireland. It is published in online and print formats, and lists original brands, branded generics and pure generic prescription medicines.

Shanthilal Devapriya Jayaratne MBBS, MD Post Graduate Institute of Medicine, Colombo, FRCP, FCCP was a professor of medicine at University of Sri Jayewardenepura and was Chairman of State Pharmaceuticals Corporation of Sri Lanka (SPC) and State Pharmaceuticals Manufacturing Corporation (SPMC). Jayaratne is the chairman of National Medicines Regulatory Authority, and former chairman of Sri Jayawardenepura General Hospital.

Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) is a campaign–public welfare scheme of Government of India. It was launched by the Department of Pharmaceuticals to provide quality medicines at affordable prices to the masses through special kendras known as Pradhan Mantri Bharatiya Janaushadhi Pariyojana Kendra (PMBJK).

References